AKOYA BIOSCIENCES INC (AKYA)
US00974H1041 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to AKYA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.57. This target is 46.91% above the current price.
AKYA was analyzed by 14 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about AKYA.
In the previous month the buy percentage consensus was at a similar level.
AKYA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-19 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-11-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-15 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-06 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-08-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-08-06 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-06-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-14 | BTIG | Maintains | Buy -> Buy |
| 2024-05-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-12-14 | Guggenheim | Initiate | Neutral |
| 2023-11-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-08-08 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-08-08 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-03-21 | Stephens & Co. | Reiterate | Overweight |
| 2023-03-08 | Morgan Stanley | Maintains | Overweight |
| 2022-11-03 | Capital One | Initiate | Overweight |
| 2022-10-06 | Stephens & Co. | Initiate | Overweight |
| 2022-08-17 | Piper Sandler | Maintains | Overweight |
| 2022-06-22 | BTIG | Initiate | Buy |
| 2022-05-16 | Piper Sandler | Maintains | Overweight |